Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tentarix Biotherapeutics
Biotech
Xaira, Anthos, CureVac & more—Chutes & Ladders
Ousted former Stanford president to lead new billion-dollar biotech. Fresh off BMS buy, Karuna’s ex-CEO to helm Anthos. CureVac names new CBO.
Max Bayer
,
Gabrielle Masson
,
Andrea Park
Apr 26, 2024 8:30am
AbbVie wraps up $64M oncology, immunology deal with Tentarix
Feb 22, 2024 9:09am
Gilead, Tentarix ink $66M oncology, inflammatory disease deal
Aug 15, 2023 10:22am
Seasoned executive team launches Tentarix with $50M
Oct 14, 2021 2:31pm